InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Leggett Thomas. Director active across 1 company, notably Stoke Therapeutics, Inc.. In total, 2 reports have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €36k. Activity tracked since 15 March 2026. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations